Hong-Ming Hu: Scaling TCR-T for solid tumors through ImmuXell's partnership with IRO®
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Hong-Ming Hu, Founder and Chief Scientific Officer of ImmuXell Biotec...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Ori Spotlight
Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down th...
Episodes
20 of 54 episodes
Ken Harris: Why AI and automation are CGT’s next inflection point
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Ken Harris, CEO of Omnia Bio and former healthcare lead at Amazon Web...
Joe DePinto: Why advanced therapies need a new delivery model
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Joe DePinto, Head of Cell and Gene Advanced Therapies at McKesson, to...
Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Jonathan Gluck, an award-winning journalist and author of An Exercise...
John Khoury: The CGT developers who adapt new manufacturing techniques early will lead later
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes John Khoury, Founder of Project Farma, to unpack how the standards fo...
Warner Biddle: Building a commercial model for CAR-T in autoimmune care
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Warner Biddle, CEO of Kyverna Therapeutics, to explore how autologous...
Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Lavakumar (Kumar) Karyampudi, Senior Director of Cell Therapies at Mo...
Henrik Andersen: How smart planning helps CGT scale further, faster
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Henrik Andersen, former SVP and Head of Cell Therapy Technology Devel...
Arsalan Arif: Investor confidence in advanced therapies is critical for long-term success
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Arsalan Arif, founder of Endpoints News, for a wide-ranging conversat...
Julie Allickson: How early automation strategies reduce costs and improve patient access
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Dr. Julie Allickson, Chief Technology Officer for Mayo Clinic's Cente...
Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 2)
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes back Aaron Vernon, Chief Manufacturing Officer at Quell Therapeutics,...
Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 1)
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Aaron Vernon, Chief Manufacturing Officer at Quell Therapeutics, for...
Amritha Jaishankar: Advancing data integration and decentralized manufacturing for CGT access
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Amritha Jaishankar, Executive Director of the Cell and Gene Therapy C...
Boro Dropulić: Simplifying CAR-T workflows will break down barriers to patient access
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Boro Dropulić, CEO of Vector Biomed and Executive Director at Caring...
Michael Krajewski: How does the Theory of Constraints apply to CGT manufacturing?
In this episode of the Ori Spotlight Podcast, Jason Foster is joined by Michael Krajewski, Director at Stand Back and an expert in engineeri...
Carl Schoellhammer: viability is the crucial third pillar in CGT
In this episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to discuss the import...
Anshul Mangal: Unlocking scale, automation, digitalization, and standardization in CGT
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Anshul Mangal, President at Project Farma, to discuss the hurdles to...
Omkar Kawalekar: technology will unlock scalability and patient access
In this episode, Omkar Kawalekar of Deloitte's NextGenTherapies practice joins Ori CEO Jason C. Foster, to explore the significance of techn...
Joe DePinto: Bridging growth and accessibility within CGTs
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Joe DePinto, head of Cell and Gene Advanced Therapies at McKesson, to...
Matthew Hewitt: scalability is a collective problem
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Matthew Hewitt, Vice President and Technical Officer of Cell and Gene...